Clinical Trials News
August 17th, 2009
The US FDA has approved Saphris sublingual tablets for the acute therapy of schizophrenic adults, as well as the acute therapy of manic or mixed bipolar I disorder, with or without adult psychotic attributes. Saphris is endorsed for first-line therapy, and is the first prescription drug to receive primary consent for both of these symptoms concurrently.
August 13th, 2009
Specialty pharmaceutical company, who specializes in the generation of revolutionary products to treat neurological and psychiatric diseases, publicizes top-line results from the Phase III Zelrix clinical tria
August 11th, 2009
Sanofi-aventis recently publicized the release of an Expert Statement issued by a board of multidisciplinary, internationally acclaimed experts, which follows an in-depth evaluation of the recent publications of registry analyses with Lantus in Diabetologia.
August 11th, 2009
The National Heart, Lung and Blood Institute (NHLBI) has halted a clinical trial involving drug treatment tests for pulmonary hypertension in adults who suffer from sickle cell disease.
August 11th, 2009
Array BioPharma Inc. has recently notified the public of their Phase 1 favorable top-line data clinical trial, conducted with a group Type 2 diabetes patients and their small molecule glucokinase activator (GKA), ARRY-403
August 7th, 2009
Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.
August 7th, 2009
The US FDA has recently approved Invega Sustenna extended-release injectable suspension for acute and maintenance therapy of adult schizophrenia. Invega Sustenna is the first US approved once a month injectable, long-acting, atypical antipsychotic.
August 7th, 2009
The mouse is aptly named “Tiny” but his small stature has nothing to do with the large effect this pocket-size rodent is having on the science community, and the world for that matter!
August 7th, 2009
The Southern Australian biotech company: Vaxine Pty. Ltd., will be the first to administer a human swine flu vaccine immunization.
August 7th, 2009
Antiretroviral drugs are proving to be safe and helpful, thanks to an international study that examined HIV transmission prevention between mother and child by way of breast milk.
